Latest Breaking News On - Hmnc brain health - Page 1 : comparemela.com

Investegate |HMNC Holding GmbH Announcements | HMNC Holding GmbH: HMNC Brain Health and Develco Pharma Announce Last Patient Being Randomized in Oral Prolonged-Release Ketamine (KET01) Trial for Treatment-Resistant Depression

Investegate announcements from HMNC Holding GmbH, HMNC Brain Health and Develco Pharma Announce Last Patient Being Randomized in Oral Prolonged-Release Ketamine (KET01) Trial for Treatment-Resistant Depression

Baden wübergSwitzerland generalSouth africaAnne donohoeSophia bashfordHans erikssonDevelco pharmaKetabon programBrain healthHolding gmbHmnc brain healthOral prolonged release ketamineTopline results expectedTreatment resistant depressionChief medical officerDepression rating scale

HMNC Brain Health Raises €14 3M in Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Wilhelm beierToni kroosMaximilian doeblerGuntard gutmannDevelco pharmaJosef ackermannCarsten maschmeyerHans kompernaHmnc brain healthBrain healthJahr groupChief business officerMajor depressive disorder

HMNC Brain Health and Develco Pharma Partner to Initiate Ketamine Study Targeting Treatment-Resistant Depression (TRD)

HMNC Brain Health and Develco Pharma Partner to Initiate Ketamine Study Targeting Treatment-Resistant Depression (TRD)
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Develco pharmaHans erikssonMarkus zimmerContract research organizationPsychiatric university clinic zurichHolding gmbHmnc brain healthBrain healthClinical developmentDevelco pharma partnerSwiss based develco pharmaChief clinical development officer